U.S. biotech company to lay off nearly one third of American staff


  • World
  • Thursday, 20 Jul 2023

SAN FRANCISCO, July 19 (Xinhua) -- U.S. biotech company FibroGen will lay off 104 workers, nearly a third of its U.S. employees, the company announced on Wednesday.

FibroGen, which is based in San Francisco, California, said it would reduce about 32 percent of its U.S. workforce and save 30 million to 35 million U.S. dollars in annual expenses in the future.

The company expects 13 million to 15 million dollars in charges related to the layoffs, including severance pay and employee benefits, according to a corporate filing.

FibroGen shares plunged by more than 85 percent in the past month and were down about 7 percent on Wednesday. The company's market capitalization is now 232 million dollars.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

No French government before Monday evening, presidency says
Russian delegation arrives in Iran for meeting with president
South Korea detects signs of North Korea preparing more troops, drones for Russia
Indonesian tsunami survivor holds on to hope for missing son after 20 years
South Korean opposition threatens to impeach Han over martial law counsel
Jeff Bezos says most people should take more risks. Here’s the science that proves he’s right
Bluesky finds with growth comes growing pains – and bots
How tech created a ‘recipe for loneliness’
New Zealand rejects Cook Islands passport plan
How data shared in the cloud is aiding snow removal

Others Also Read